Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Paolo Ghia, Andrzej Pluta, Małgorzata Wach, Daniel Lysák, Tomáš Kozák, Martin Šimkovič and 14 more
- Rank
- 38 of 453
- Percentile
- top 8.4%
- Where
- Journal of Clinical Oncology, 2020
- Citations
- 372
From the 2020 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.